Here's the document in question:
Pfizer. (With Worldwide Safety). "5.3.6 CUMULATIVE ANALYSIS OF POST-AUTHORIZATION ADVERSE EVENT REPORTS OF PF-07302048 (BNT162B2) RECEIVED THROUGH 28-FEB-2021." Online at Public Health and Medical Officials for Transparency. (Nov. 2021).*
https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf
2021
—oOo—
No hay comentarios:
Publicar un comentario
Se aceptan opiniones alternativas, e incluso coincidentes: